{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:03:52Z","timestamp":1777539832781,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.10.066","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T01:32:34Z","timestamp":1321234354000},"page":"116-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study"],"prefix":"10.1016","volume":"30","author":[{"given":"Veronika","family":"U\u010dakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Poljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Klavs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2011.10.066_bib0005","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/aje\/kwp390","article-title":"Impact of improved classification on the association of human papillomavirus with cervical precancer","volume":"171","author":"Castle","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens \u2013 Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2011.10.066_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0045","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejca.2009.07.019","article-title":"HPV infection in Europe","volume":"45","author":"De Vuyst","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0050","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0055","unstructured":"European Medicines Agency. Silgard. Summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000732\/WC500051549.pdf [accessed on: 10.3.2011]."},{"key":"10.1016\/j.vaccine.2011.10.066_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0065","unstructured":"European Medicines Agency. Cervarix. Summary of product characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000721\/WC500024632.pdf [accessed on: 10.3.2011]."},{"key":"10.1016\/j.vaccine.2011.10.066_bib0070","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.ejca.2009.07.025","article-title":"Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union","volume":"45","author":"Nicula","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0075","unstructured":"Society for gynecological oncology, colposcopy and cervical pathology. Slovenian guidelines for management of pathological cervical smears. In Slovene: Zdru\u017eenje za ginekolo\u0161ko onkologijo, kolposkopijo in cervikalno patologijo. Smernice za celostno obravnavo \u017eensk s predrakavimi spremembami materni\u010dnega vratu. Available at: http:\/\/zora.onko-i.si\/data\/C1%20-%20Smernice%20za%20celostno%20obravnavo.pdf [accessed on: 6.2.2011]."},{"key":"10.1016\/j.vaccine.2011.10.066_bib0080","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JCM.00012-11","article-title":"Comparison of clinical and analytical performance of the Abbott RealTime High Risk HPV Test and Hybrid Capture 2 in population-based cervical cancer screening","volume":"49","author":"Poljak","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/eri.10.104","article-title":"Commercially available assays for multiplex detection of alpha human papillomaviruses","volume":"8","author":"Poljak","year":"2010","journal-title":"Exp Rev Anti Infect Ther"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0090","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","article-title":"Principles and analytical performance of Abbott RealTime High Risk HPV Test","volume":"45","author":"Huang","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0095","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"WHO Human Papillomavirus Laboratory Network. Global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.10.066_bib0100","unstructured":"Slovenian National Cervical Cancer Screening Programme (DP ZORA) in pictures; January 2011. In Slovene: DP ZORA v slikah. Available at: http:\/\/zora.onko-i.si\/data\/DP_ZORA_v_slikah_2011.pdf [accessed on 26.4.2011]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:19:25Z","timestamp":1759400365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11017038"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.10.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}